Home/Filings/4/0001209191-23-055447
4//SEC Filing

Conway Vikki L 4

Accession 0001209191-23-055447

CIK 0000818686other

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 7:36 AM ET

Size

6.0 KB

Accession

0001209191-23-055447

Insider Transaction Report

Form 4
Period: 2023-11-15
Conway Vikki L
See "Remarks"
Transactions
  • Award

    Restricted Share Units

    2023-11-15+33,48233,482 total
    Ordinary Shares (33,482 underlying)
Footnotes (3)
  • [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F2]Restricted share units were granted on November 15, 2023, with 8,370 vesting on each of November 15, 2024, November 15, 2025 and November 15, 2026, and 8,372 vesting on November 15, 2027.
  • [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001995297

Filing Metadata

Form type
4
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 7:36 AM ET
Size
6.0 KB